Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma. - Sperling AS; Derman BA; Nikiforow S; Alonso A; Ikegawa S; Orwitz N; Quinn DS; Pearson D; Bu D; Milanez-Almeida P; Mataraza J; Nadeem O; et al. (Science translational medicine, 2026)